FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 2169. Misbranding of estrogenic substances. U. S. v. Harvey Laboratories, Inc., and Aaron Lichten. Pleas of nolo contendere. Fines of $150 against the corporation and $1 against the individual. ✖Remove constraint Titles: 2169. Misbranding of estrogenic substances. U. S. v. Harvey Laboratories, Inc., and Aaron Lichten. Pleas of nolo contendere. Fines of $150 against the corporation and $1 against the individual. Product Keywords estrogenic substances ✖Remove constraint Product Keywords: estrogenic substances

Refine by:

  • 2169. Misbranding of estrogenic substances. U. S. v. Harvey Laboratories, Inc., and Aaron Lichten. Pleas of nolo contendere. Fines of $150 against the corporation and $1 against the individual.1